An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer
Clinical trial NCT00580112 · COMPLETED
Trial details
- NCT number
- NCT00580112
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2011-08-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.